Loading clinical trials...
Loading clinical trials...
In this study, Human Papilloma Virus (HPV) prevalence will be determined once in the urine of 200 trans people. In addition, subjects will be asked to complete a questionnaire about their sexual orien...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sophie Pils
NCT07550010 · Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia Grade 2 (CIN2), and more
NCT04226313 · Cervical Cancer, Cervical Dysplasia, and more
NCT05266898 · Papillomavirus Vaccines, Human Immunodeficiency Virus, and more
NCT05860725 · Human Papillomavirus Infection, Vaccination Hesitancy
NCT05918510 · Squamous Cell Carcinoma of the Oropharynx, Carcinomas of Unknown Primary Site, and more
Medical University of Vienna
Vienna
Institute of Microbiology and Immunology Faculty of Medicine
Ljubljana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions